The interleukin 4 (IL-4) signaling pathway involves activation, by tyrosine phosphorylation, of two distinct substrates, a signal-transducing factor (STF-IL4) and the IL-4-induced phosphotyrosine substrate (4PS). It is not known whether the IL-4-mediated activation of these substrates occurs via related or distinct signaling pathways. We report that 32D cells, an IL-3-dependent myeloid progenitor cell line in which no phosphorylated 4PS is found, activate high levels of STF-IL4 in response to (1). The biologic functions of IL-4 are mediated via its binding to a specific cell surface receptor. This receptor, which is widely distributed, has been found to consist of two chains that are members of the type I cytokine receptor superfamily (2), a ligand-binding chain (IL-4R) and a chain, the y common ('ye) chain, that is shared with the IL-2, IL-7, IL-9, and IL-15 receptors (3) (4) (5) (6) (7) (8) 28) .
IL-7, IL-9, and IL-15 receptors (3) (4) (5) (6) (7) (8) 28) .
The ability of IL-4 to stimulate cellular proliferation of the IL-3-dependent myeloid progenitor cell line 32D is dependent on the expression of either IL-4-induced phosphotyrosine substrate [4PS, also termed insulin receptor substrate 2 (IRS-2)] or the antigenically related IRS-1 (a substrate of the insulin receptor kinase) (9, 10) . Studies with truncation mutants of the human IL-4R (hIL-4R) have revealed that the region spanning hIL-4R aa 437-557 is essential for IRS-1 phosphorylation and cell proliferation (11) . This region contains an insulin receptor motif which includes a tyrosine at position 497. Mutation of tyrosine to phenylalanine (Y497F) results in the inability to adequately phosphorylate IRS-1 and, in most cell lines, to proliferate in response to IL-4. Interestingly, in addition to interacting with IRS-1, the region from the murine IL-4R (mIL-4R) containing aa 437-557 has been shown to coprecipitate an unidentified tyrosine kinase activity (11) .
In addition to 4PS phosphorylation, IL-4 can stimulate, presumably via its activation of Jak-1 and Jak-3 kinases (12, 13) , the rapid tyrosine phosphorylation of another substrate, a latent cytoplasmic factor, Stat6 (also termed IL-4 Stat) (14) . Phosphorylation allows Stat6 to dimerize, forming a signaltransducing factor (STF-IL4) which can then undergo nuclear translocation. Once in the nucleus, STF-IL4 binds to specific DNA sequences related to the interferon (IFN) y activation site (GAS) (15) (16) (17) . IL-4 response elements containing these sequences have been identified in the promoters of a variety of genes-e.g., the immunoglobulin heavy-chain germline a promoter and CD23-whose transcriptional activation is stimulated by IL-4. Recently, a 27-bp segment from the immunoglobulin heavy-chain germline s promoter which contains the STF-IL4 binding site has been shown to confer IL-4 inducibility on a minimal c-fos promoter (18) .
The ability of IL-4 to stimulate the activation of distinct substrates raises the question of how these signaling pathways are related. One possibility is that the 4PS/IRS-1 pathway, which has been shown to be critical for IL-4-induced proliferation in one system, may be independent of the Janus kinase (JAK)-signal transducers and activators of transcription (STAT) pathway. Alternatively, the activation of STF-IL4 might be integrally related to the activation of 4PS/IRS-1. Therefore, we have characterized the relationship between 4PS and STF-IL4 by assessing the ability of 32D cells, in which 4PS phosphorylation does not occur, to activate STF-IL4. We found that STF-IL4 induction was not affected by the absence of 4PS/IRS-1. Moreover, the presence of STF-IL4 was not sufficient to turn on c-myc expression. To determine whether, as already described for the IL-2 receptor ,3 chain (19) , different regions of the IL-4R chain might be linked to the activation of distinct signaling cascades, we investigated the ability of 32D cells transfected with IL-4R truncation mutants to activate STF-IL4. Surprisingly, induction of STF-IL4, as well as phosphorylation of Jak-3, required the presence of the hIL-4R region aa 437-557, which has been shown to be critical for 4PS/IRS-1 phosphorylation and cell proliferation. Thus, although STF-IL4 induction can occur without 4PS/IRS-1 phosphorylation, the activation of these molecules requires similar regions within IL-4R, suggesting that their activation might require common factors.
MATERIALS AND METHODS
Cells and Reagents. The 32D cell line was cultured in RPMI 1640 medium supplemented with 15% fetal bovine serum, 50
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,uM 2-mercaptoethanol, 2 mM L-glutamine, and 5% WEHI-3B conditioned medium (9) . Derivation and culture conditions of 32D cells overexpressing mIL-4R in the presence (32D.IL4R.IRS-1) or absence (32D.IL4R) of rat IRS-1 have been described (10) . 32D cells expressing the wild-type hIL-4R or various deletion (d557 and d437) or substitution (Y497F) mutants were prepared and maintained as described (11) . Cytokine treatments were as follows. 32D cells overexpressing mIL-4R with or without IRS-1 were either stimulated with murine IL-4 (400 units/ml; DNAX) or resuspended in RPMI 1640 medium containing WEHI conditioned medium for 15 min at 37°C for electrophoretic mobility-shift assay (EMSA) or for 30 min at 37°C for Northern blot analysis. 32D cells carrying wild-type or mutant hIL-4R were stimulated with either recombinant murine IL-4 (400 units/ml; DNAX) or recombinant human IL-4 (100 units/ml; Schering-Plough) for 15 min at 37°C for EMSA or for 30 min to 4 hr at 37°C for Northern analysis. Prior to cytokine treatment, all cells were deprived of IL-3 for 2 hr.
EMSAs and Cell Extracts. The preparation and use of oligodeoxynucleotide probes for EMSAs have been described (15, 20) . The IRF-1 GAS probe employed in these studies was 5 '-gatcGATTTCCCGAAAT-3'. Whole cell extracts were prepared as described (15, 20) .
Immunoprecipitations. Extracts were immunoprecipitated with a Jak-3 antiserum (9, 12) . The precipitates were fractionated by SDS/7% PAGE prior to immunoblotting with antiphosphotyrosine antibody 4G10 (Upstate Biotechnology, Lake Placid, NY). Bands were detected by enhanced chemiluminescence (ECL; Amersham).
Northern Analysis. Total RNA was extracted by lithium chloride. Northern blot analysis was performed with 10 ,ug of total RNA according to standard protocols. The blot was probed with either a murine c-myc cDNA or a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA labeled by random hexamer priming.
RESULTS
Presence of 4PS/IRS-1 Is Not Required for STF-IL4 Activation. To determine whether STF-IL4 activation can occur independently from that of 4PS/IRS-1, we stimulated 32D cells with IL-3 or IL-4 for 15 min. We then prepared whole cell extracts and assayed them for the induction of DNA-binding activity as detected by EMSA using the GAS element from the IRF-1 gene as a probe (Fig. 1) . Previous work has shown that both STF-IL3 (the IL-3-inducible signal-transducing factor) and STF-IL4 bind this element (20) . Extract extract from IL-4-stimulated cells revealed a GAS binding activity. IL-3, which is required for the growth of these cells (10) , induced a complex whose mobility was clearly distinct from that of STF-IL4. Interestingly, extract from IL-4-stimulated 32D cells which had been transfected with mIL-4R (32D.IL-4R), IRS-1 (32D.IRS-1), or both (32D.IL4R.IRS-1) (10) exhibited an STF-IL4 complex of intensity similar to that of the parent 32D cell line ( Fig. 1 min. Whole cell extracts were then tested in EMSAs (Fig. 3) . When the transfectant carrying the wild-type hIL-4R was stimulated with either murine or human IL-4, a GAS binding activity of equivalent intensity was detected. In contrast, when the d557 mutant was cultured with human IL-4, lower levels of STF-IL4 were induced than upon stimulation of these cells with murine IL-4. The d437 transfectant was unable to activate STF-IL4 in response to human IL-4. These same cells were able to activate STF-IL4 in respQnse to murine IL-4. These data indicate that the hIL-4R region between aa 437 and 557 is important in STF-IL4 activation. Maximal induction of STF-IL4, however, requires additional receptor regions.
Optimal STF-IL4 Activation Requires a Tyrosine at Position 497 of hIL-4R. The hIL-4R region from aa 437 to aa 557 contains a sequence motif which is also found in members of the insulin receptor family (11) . Within this consensus sequence there is a highly conserved tyrosine residue (at position 497) whose replacement with a phenylalanine residue profoundly affects 4PS/IRS-1 phosphorylation and, in most cases, IL-4-mediated proliferation. To determine whether this tyrosine is critical for STF-IL4 induction, we investigated the ability of Y497F mutants to activate STF-IL4. Cells from various Y497F transfectants were cultured with either murine or human IL-4 as described above. Whole cell extracts were then assayed by EMSA (Fig. 4) indicate that the tyrosine-497 is important, although not absolutely necessary, for induction of STF-IL4. IL-4R Region from aa 437 to aa 557 Is Necessary for Jak-3 Phosphorylation. IL-4 stimulation leads to the activation, via tyrosine phosphorylation, of two distinct members of the JAK family of kinases, Jak-1 and Jak-3 (12, 13). As has been shown for other cytokines (23, 24) , these two kinases are believed to associate with IL-4R and to be responsible for the phosphorylation, and subsequent complex formation, of STAT proteins-e.g., Stat6-which are specifically recruited to the IL-4R. To evaluate whether the inability to detect STF-IL4 in the d437 transfectant correlates with the inability to activate the JAK kinases, we stimulated cells from the different truncation mutants with either murine or human IL-4 as described above. Extracts from these cells were then immunoprecipitated with an antiserum directed against Jak-3. The precipitated proteins were separated by SDS/PAGE for immunoblot analysis with an anti-phosphotyrosine antibody (Fig.  5) . As already observed for STF-IL4 activation, the transfectant carrying wild-type hIL-4R was able to respond to human IL-4 by inducing phosphorylation of Jak-3 in an amount similar to that detected in response to murine IL-4. The d557 mutant, instead, exhibited a lower level of Jak-3 phosphorylation in response to human IL-4 than in response to murine IL-4. The d437 transfectant was unable to respond to human IL-4 with detectable levels of Jak-3 phosphorylation but retained its ability to phosphorylate Jak-3 upon stimulation with murine IL-4. Reprobing this fiiter with a Jak-3 antiserum confirmed that cells from the different transfectants contained equivalent amounts of Jak-3 (data not shown). Thus, Jak-3 phosphorylation is impaired when the IL-4R region from aa 437 to aa 557 is missing. In parallel to the results obtained for STF-IL4, optimal Jak-3 activation requires regions of the IL-4R in addition to aa 437-557.
IL-4-Mediated Proliferation Correlates with IL-4 Induction of c-myc Expression. All of the Y497F transfectants have lost their ability to phosphorylate 4PS/IRS-1 (11) . One of the Y497F mutant lines (8-5D3), however, still proliferates in response to IL-4 (11). To determine whether IL-4-mediated proliferation in this cell line correlates with IL-4-induced c-myc expression, we carried out Northern blot analysis of RNA hIL-4R mutants which had been cultured with murine or human IL-4 (Fig. 6A) . In the Y497F mutants, induction of c-myc in response to IL-4 was seen only in the mutant (8-5D3) which is still able to proliferate in response to IL-4. Interest-
Effects of hIL-4R deletion mutations on Jak-3 activation. Transfectants expressing the wild-type hIL-4R (WT) or transfectants expressing truncations of this chain to aa 557 (d557) or to aa 437 (d437) were cultured for 15 min without cytokine (-) or with either human IL-4 (h) or murine IL-4 (m). Extracts were prepared from cells as described in Fig. 2 . Extracts were then immunoprecipitated with a Jak-3 antiserum. The proteins were separated by SDS/7% PAGE and analyzed by Western blotting using an anti-phosphotyrosine antibody.
The blot was subsequently stripped and reprobed with a Jak-3 antiserum, which revealed equivalent levels of Jak-3 among the different extracts (data not shown). Positions of 200-kDa and 97-kDa size markers are shown. (24) , IL-4R aa 437-557 may be essential for optimal Jak-1 activation-e.g., by allowing specific conformational changes or effective Jak-1/Jak-3 cross-phosphorylation.
The increasing inability to activate STF-IL4 by transfectants carrying progressively larger deletions of the intracytoplasmic region of hIL-4R is in accordance with recent studies showing that Stat3 activation by the IL-6 family of cytokines depends on specific modular tyrosine-based motifs (26) . Thus 
